Naproxen Genericon

Naproxen, the active ingredient in Naproxen Genericon, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as a tablet for oral use. It is used to relieve pain, reduce inflammation and lower fever in adults and adolescents.

GNH USA supplies Naproxen Genericon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen acts as an NSAID that reduces inflammation and pain across several common conditions.

- Pain: provides analgesic relief for mild to moderate musculoskeletal pain. - Inflammation: diminishes swelling associated with soft‑tissue injuries. - Arthritis: eases joint pain and stiffness in osteoarthritis and rheumatoid arthritis. - Dysmenorrhea: lessens menstrual cramps and associated discomfort. - Fever: lowers elevated body temperature in febrile states.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate tension‑type headaches. - Dizziness: transient light‑headedness. - Rash: mild skin erythema or itching. - Elevated blood pressure: modest rise in systolic/diastolic values.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Renal impairment: reduced kidney function or acute failure. - Hepatotoxicity: abnormal liver enzymes or hepatitis. - Cardiovascular events: increased risk of heart attack or stroke. - Severe hypersensitivity: anaphylaxis or Stevens‑Johnson syndrome.

Before prescribing Naproxen, clinicians should evaluate patient‑specific risk factors.

- Assess renal function: avoid in severe renal impairment. - Evaluate hepatic status: use cautiously in liver disease. - Review cardiovascular history: consider alternatives in high‑risk patients. - Monitor gastrointestinal risk: avoid in active ulcer disease or bleeding disorders. - Check concomitant medications: avoid with other NSAIDs or anticoagulants when possible. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Naproxen may alter the effect of several co‑administered drugs.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Selective serotonin reuptake inhibitors (SSRIs): heightened gastrointestinal bleeding. - ACE inhibitors or ARBs: potential reduction in renal function.

Moderate Interactions (Monitor Closely): - Diuretics: may diminish antihypertensive effect. - Lithium: possible rise in serum lithium levels. - Methotrexate: reduced clearance leading to toxicity.